“…The cyclooxygenase inhibitor, indomethacin (40 g/mL perfusate), was added to block the potentially confounding effects of dilator prostaglandins, as previously described. 22 The perfusate exited the left atrium to a reservoir from which it was pumped (Varistaltic Roller Pump, Manostat, New York, NY) through a heat exchanger, filter/bubble trap, and flow probe (model EP 300 flow probe and model 501 flow meter, Carolina Medical Electronics, King, NC) to the pulmonary artery. Pulmonary artery pressure (Ppa), left atrial pressure (Pla), and airway pressure (Paw) were constantly measured (Statham 23id pressure transducers, Spectramed, Oxnard, CA) and recorded on a polygraph (model 7D, Grass Instrument Co., Quincy, MA).…”